Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

PHASE3CompletedINTERVENTIONAL
Enrollment

538

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Major Depressive Disorder
Interventions
DRUG

venlafaxine ER 75 mg/day (fixed dose)

Treatment phase: 8 weeks (37.5 mg/day for 1st week and 75 mg/day for 7 weeks), oral administration Tapering phase: 2 weeks (37.5 mg/day for the 1st week and placebo for the 2nd week), oral administration

DRUG

venlafaxine ER 75 mg/day to 225 mg/day (flexible dose)

Treatment phase: 8 weeks (37.5 mg/day for the 1st week, 75 mg/day for the 2nd weeks, 75-150 mg for the 3rd week, 75-225 mg/day for the rest of 5 weeks), oral administration Tapering phase: 2 weeks (75/37.5 mg/day for the 1st week and 37.5 mg/day/placebo for the 2nd week), oral administration

DRUG

Placebo

Treatment phase: 8 weeks (placebo), oral administration Tapering phase: 2 weeks (placebo), oral administration

Trial Locations (63)

8100041

Akasaka Kato Clinic, Fukuoka

458-0801

Narumi Himawari Clinic, Nagoya

467-0806

Mizuho Clinic, Nagoya

270-1694

Nippon Medical School Chiba Hokusoh Hospital, Inzai

270-0163

Hida Clinic, Nagareyama

278-0033

Nakamoto Clinic, Noda

814-0104

Hatsuki Shinryo Clinic, Fukuoka

802-0064

Hatakeyama Clinic, Kitakyushu-shi

836-0004

Shiranui Hospital, Omuta

836-0044

Oka Clinic, Omuta

738-0023

Fujikawa Clinic, Hatsukaichi

737-0111

Hayakawa Clinic, Kure

001-0023

Kawamura Mental Clinic, Sapporo

064-0820

Maruyamapark Mentalclinic, Sapporo

660-0882

Arai Clinic, Amagasaki

659-0093

Takahashi Psychiatric Clinic, Ashiya

651-0097

Tatsuta Clinic, Kobe

655-0037

Ikeuchi Psycho Induced Internal Med.Clinic, Kobe

920-8650

National Hospital Organization Kanazawa Medical Center, Kanazawa

214-0014

Medical Corporation Seishinkai Kishiro Mental Clinic, Kawasaki

252-0303

Yutaka Clinic, Sagamihara

225-0011

Azamino Mental Clinic, Yokohama

238-0042

Shioiri Mental Clinic, Yokosuka

861-8002

Yuge Hospital, Kumamoto

573-0032

Kuginuki Clinic, Hirakata

589-0011

Shibamoto Clinic, Osakasayama-shi

330-0062

Sakai Mental Clinic, Saitama

120-0033

Suzuki Hospital, Adachi-ku

102-0071

Iidabashi Mental Clinic, Chiyoda-ku

182-0006

Tutujigaoka Mental Clinic, Chōfu

125-0041

Fuku Clinic, Katsushika-ku

106-0032

SAKURAZAKA CLINIC SophyAnce, Minato-ku

107-0052

Akasaka Clinic, Minato-ku

164-0001

Harikae mental clinic, Nakano-Ku

164-0012

Heartcare Ginga Clinic, Nakano-ku

154-0004

Sangenjaya Nakamura Mental Clinic, Setagaya-ku

154-0012

Komazawa Mental Clinic, Setagaya-ku

150-0001

Omotesando Mental Clinic, Shibuya-ku

151-0053

Maynds Tower Mental Clinic, Shibuya-ku

Yoyoginomori Mental Clinic, Shibuyaku

141-0021

Meguro sta.East Mental Clinic, Shinagawa-ku

141-0032

Himeno Tomomi Clinic, Shinagawa-Ku

160-0023

Nishi-Shinjuku Concieria Clinic, Shinjuku-ku

Tamaki Clinic, Shinjuku-ku

162-0825

Kagurazaka Stress Clinic, Shinjuku-ku

162-8543

Tokyo Kosei Nenkin Hospital, Shinjuku-ku

162-8666

Tokyo Women's Medical University Hospital, Shinjuku-ku

170-0002

Himorogi Psychiatric Institute, Toshima-ku

810-0001

Sugahara Tenjin Clinic, Fukuoka

810-0004

Hiro Mental Clinic Tenjinminami, Fukuoka

Tenjin Mental Clinic, Fukuoka

810-0022

Medical Corporation Shinseikai Kaku Mental Clinic, Fukuoka

810-0035

Ange Psychiatric Clinic, Fukuoka

810-0041

Stress Care Yoshimura Clinic, Fukuoka

810-0801

Kuranari Psychiatry Clinic, Fukuoka

815-0041

Imato Clinic, Fukuoka

731-0112

Tsuji Mental Clinic, Hiroshima

221-0835

Medical Corporation Toyokokai Tawara Clinic, Kanagawa

616-8421

Sagaarashiyama-Tanaka Clinic, Kyoto

631-0036

Kyo Mental Clinic, Nara

530-0041

JIN clinic, Osaka

341-0018

Misato Ekimae Clinic, Saitama

142-0021

Eto Mental Clinic Meguro, Tokyo

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01441440 - Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter